D
uring the past 2 decades, major advancements have been made in the early diagnosis of stroke and timeliness of treatment. 1 Although intravenous tissue plasminogen activator (IV tPA) has played a vital role in decreasing morbidity and mortality associated with the disease, factors such as implementation of stroke registries, hospital certifications, and quality improvement initiatives have also contributed to the better care and outcomes of patients with acute ischemic stroke (AIS). [2] [3] [4] It has been demonstrated that the emergency department (ED) staff and physicians at smaller health centers can diagnose stroke appropriately, but the management of patients with complex stroke or multiorgan involvement requires a greater degree of resources and a higher intensity of care. 5 For these situations, regionalization of acute stroke care has been implemented, transferring these stroke patients to primary or comprehensive stroke centers. Comprehensive stroke centers are able to treat patients with AIS of all complexity levels and offer specialized care and interventions such as intra-arterial thrombolysis/mechanical thrombectomy, decompressive hemicraniectomy, and neurointensive care. 6 This regionalization of care has also increased the rate of IV tPA administration. The ability to transfer patients to an advanced stroke care center for post-tPA management has made smaller hospitals comfortable in administering IV tPA.
can oversee the initial acute stroke management and administer IV tPA; if needed, patients can be transferred for further consideration of intra-arterial therapy or post-tPA management. 8, 9 Accumulation of patients with severe stroke and posttPA-treated patients at comprehensive stroke care centers has raised concerns about whether such centers would be unfairly assessed by public reporting programs that measure mortality but do not risk adjust for stroke severity. By accepting severe stroke patients directly via the front door or in transfer from smaller regional hospitals, comprehensive stroke centers are treating patients with higher expected mortality and thus possibly worsening their publicly reported measures. We performed a retrospective analysis comparing the characteristics, outcomes, and in-hospital mortality of patients presenting directly to our front door ED as compared with those transferred from another hospital for advance stroke care.
Methods

Patient Population
Using our hospital's local stroke registry which is collected as part of our participation in the Get With The Guidelines-Stroke (GWTGStroke) registry, we analyzed patients consecutively admitted with AIS. Our hospital, although not formally certified, fits the criteria set by Joint Commission for a comprehensive stroke center. We manage >1000 patients with stroke per year, have advanced imaging capabilities, dedicated neurointensive care units, monthly and quarterly peer-reviewed meetings to discuss performance measures and IV tPA complications, and participate in multiple stroke registries.
GWTG-Stroke is an ongoing voluntary, continuous registry and performance improvement initiative. Site personnel collect and enter deidentified patient level data on clinical and demographic characteristics, diagnostic testing, treatments, adherence to quality measures, and in-hospital outcomes in patients hospitalized with stroke. Trained hospital personnel ascertain consecutive patients admitted with stroke by either prospective clinical identification, retrospective identification using International Classification of Diseases, Ninth Revision (ICD-9) discharge codes, or a combination. Prospective identification includes regular surveillance of ED records (ie, presenting symptoms and chief complaints), ward census logs, and neurological consultations. The eligibility of each acute stroke is confirmed at chart review before abstraction. After abstraction by trained personnel at hospital, deidentified patient data are entered into the GWTG-Stroke database using a Web-based patient management tool (PMT, Outcome, Quintiles). Data abstracted include patient demographics, medical history and comorbidities, calendar year, initial head computerized tomography findings, in-hospital treatment and events, discharge treatment and counseling, mortality, and discharge destination.
After excluding patients with possible transient ischemic attacks and stroke mimics, our cohort consisted of 3660 patients with AIS admitted from January 2005 until June 2012. Data on demographics, comorbidities, National Institutes of Health Stroke Scale (NIHSS) at the time of admission, in-hospital interventions, hospital complications, length of stay, discharge disposition, and mortality were collected and analyzed. We obtained institutional review board approval to conduct this retrospective analysis including medical record review of our database.
Definitions
Front Door Versus Transfer-in
All patients were classified into 2 groups. The first group consisted of patients with AIS first presenting to the front door at our comprehensive stroke center. The second group consisted of patients with AIS transferred (transfer-in) from another acute healthcare facility or outside hospital (OSH) where they originally presented. Transfer-in patients with AIS were transferred from an OSH ED to our ED or from an OSH inpatient unit to our inpatient unit.
Our stroke center receives transfers from many different nearby hospitals, but the majority of the transfers come to us from hospitals that are already engaged as spokes in our regional telestroke network. Spoke hospitals in our network are community hospitals in Massachusetts, Maine, and New Hampshire. A few have on-site neurology coverage and use our system as a backup, but the vast majority relies on our service to provide acute neurology consultation. All can provide acute tPA therapy, but only 1 or 2 can manage these patients post-treatment. Several are critical access hospitals that transfer us all their patients with stroke. Because we have 24/7 endovascular services, we also get patients with suspected large artery occlusion transferred from a wider array of sites.
GWTG-Stroke In-Hospital Measures
Inpatient management including performance of dysphagia screening, use of early antithrombotics, and deep vein thrombosis/pulmonary embolism prophylaxis were all recorded at the patient level according to GWTG-Stroke definitions. To avoid bias introduced by the fact that inpatient transfers are not eligible for GWTG measures, we chose to report absolute rates of these interventions across all patients without applying any exclusion for ineligibility.
Outcome
The primary outcome of interest for this study was in-hospital mortality, which was defined as patients who expired during their stay in the ED or during the hospital stay, or who were discharged to hospice. Hospital length of stay and discharge disposition were also analyzed as secondary outcomes. Discharge disposition was divided into favorable (home and inpatient rehabilitation facility) and unfavorable (skilled nursing facility and death/hospice). We had in-hospital mortality and discharge data for all 3660 patients included in the study.
Statistical Analysis
Descriptive statistics of characteristics associated with transfer status (front door versus transfer-in) were generated using contingency tables, and χ 2 analysis for dichotomous variables (sex, race, comorbidities, in-hospital interventions, discharge disposition, and in-hospital mortality) and independent sample t test and Wilcoxon rank-sum test for continuous ordinal or non-normal continuous variables (age, NIHSS, length of stay, and last known well to IV tPA) were performed. All tests of statistical significance were 2-tailed and considered to be significant at P<0.05.
The crude association between transfer status and outcomes was quantified using univariate odds ratios (ORs) with 95% confidence intervals were computed for all variables but reported for only those variables that were significant in univariate testing at P<0.1. To determine the independent effects of transfer status and other important baseline variables present at the time of admission, we performed multivariable logistic regression. Because many patients had already received IV tPA before arriving at our ED, we performed a second multivariable analysis in which IV tPA status for all the patients with AIS was adjusted for in the model as well. In addition, we performed a secondary analysis that explored the association between transfer status and outcomes only in the cohort of patients receiving IV tPA. Statistical analyses were performed using the software SPSS version 20.0.
Results
We identified a total of 3660 patients with AIS from January 2005 to June 2012. Mean age was 69.3±15.3 years; 55% of patients were male and 87% were white. Vascular risk factors were frequent with hypertension being the most common in 69% of patients, hyperlipidemia in 42%, diabetes mellitus in 24%, coronary artery disease in 23%, and peripheral vascular disease in 5%. Atrial fibrillation was present in 23% of patients with AIS (Table 1) . A total of 9% of patients with AIS had a prior episode of stroke. Twenty percent of patients were treated with
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IV tPA, whereas 6% received intra-arterial reperfusion therapy. Regardless of eligibility, the crude rates of evidence-based interventions were high, with most of the patients receiving early antithrombotics (92%), dysphagia screening (78%) before commencement of oral intake, and deep vein thrombosis prophylaxis (98%) within 48 hours of arrival. Common complications recorded were in-hospital pneumonia in 7% and urinary tract infection in 8%. In-hospital mortality was 12%, and overall, 13% of patients with AIS had an unfavorable outcome, defined as discharge to an skilled nursing facility, hospice, or death.
Of the 3660 patients with AIS, 1840 (50.3%) presented to our front door and 1820 (49.7%) were transferred from an OSH. Among transfer-in patients, 89% were transferred from an OSH ED to our ED, whereas 11% were from OSH inpatient to our inpatient. Transfer-in patients were observed to be younger and less racially diverse but did not differ significantly in vascular risk factors with the exception of diabetes mellitus and heart failure. As compared with patients presenting via the front door, transfer-in patients had more severe stroke disability at first presentation as measured by higher median NIHSS and greater likelihood of presenting with weakness or aphasia ( Table 1) . A greater percentage of transfer-in patients received IV tPA, with the majority of IV tPA having been started before transfer. Last known well to IV tPA time was longer for transfer-in patients. The rates of adherence to evidence-based practices were similar for the 2 groups once they arrived at Massachusetts General Hospital, as shown by rates of dysphagia screening, antithrombotic use, and deep vein thrombosis prophylaxis. Both cohorts had similar rates of in-hospital complications ( Table 2 ).
Short-term Outcomes
We observed the same rates of unfavorable outcomes in the 2 groups (Table 2 ). There was a trend toward higher in-hospital All univariate predictors of in-hospital mortality present at the time of admission with P≤0.1 were included in a logistic regression model in order to examine their independent association with in-hospital mortality. In adjusted analysis for factors present on arrival, older age, history of atrial fibrillation, coronary artery disease, and higher NIHSS at presentation remained significantly associated with higher rates of mortality. Transfer status was not significant in multivariable adjusted analysis (OR, 0.99 [0.76-1.29]; P=0.93). Because so many patients received IV tPA before arrival at our hospital, we repeated these models including a term for IV tPA. When this was performed, there were no changes in the observed adjusted ORs (Table 3 ).
Thrombolysis
Of the 3660 patients included in this study, 754 (20.6%) received IV tPA; of the 754 patients, 522 (69%) were transfer-in patients. To assess the impact of thrombolysis, we also ran a sensitivity analysis restricted to the cohort who received tPA. Baseline demographics and clinical characteristics with outcomes (discharge disposition and in-hospital mortality) are shown in Table 4 . Although we observed that a similar number of patients were discharged home in both the cohorts, a greater percentage of thrombolysed transfer-in patients were discharged to inpatient rehabilitation facility and they had lower mortality as compared with front door IV tPA patients. Factors associated with higher mortality in this cohort were similar to those in the total cohort and included age (OR, 
Discussion
This study demonstrates that transfer-in patients were significantly more severely disabled at presentation and more likely to receive tPA than patients arriving at our front door. Despite this increased severity that likely translates into a higher risk of mortality, in-hospital mortality and discharge disposition were similar among consecutively admitted patients with AIS at our major regional stroke center whether they were admitted via the front door or transferred from another acute care hospital. This finding held true when restricted to tPA-treated patients. Our observation supports the concept of regionalized stroke care as a viable model to deliver acute stroke treatment and care across a large geographic area.
Advanced stroke care centers and comprehensive stroke centers provide specialized care and offer advanced interventions, such as intra-arterial thrombolysis/mechanical thrombectomy, neurosurgical, and neurointensive care, requiring specialized infrastructure and personnel. 6, 10, 11 Such centers accept patients 
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with major stroke syndromes from less-resourced hospitals that lack the specialized capability and human expertise needed to provide this higher level of care. The ability of our regional stroke system of care to offer a higher level of services when needed has also likely made smaller hospitals more comfortable in administering IV tPA to patients with acute stroke. 7, 12, 13 This comfort level may be additionally increased through our existing telemedicine links to these hospitals, which may further facilitate tPA delivery in eligible patients. This regionalization of care is gaining support, but there is a lack of medical literature reflecting its effectiveness. Concentrating patients with stroke who are severely disabled at 1 regional center not only increases the human resources and financial burdens at the regional center, but also potentially increases the in-hospital mortality rates at this center because initial stroke severity is the strongest known predictor of mortality after ischemic stroke. 14 We sought to test this hypothesis in our large cohort of patients from a regional stroke network. In our data, crude mortality of patients presenting directly to our hospital (front door patients) was 10.6% as compared with 12.5% in patients transferred from an OSH. However, on multivariate analysis, the mortality rates were similar despite transfer-in patients having a 3-point higher median NIHSS and longer onset to treatment times among those receiving IV tPA. These data seem to suggest that regionalization of care is not associated with increased mortality at a comprehensive stroke center after adjustment for confounding variables. These results may reflect the fact that centers with high volumes of patients with stroke achieve better outcomes in cerebrovascular disease by successful application of evidence-based care, higher volumes of practice, or other unmeasured confounders. 15 It is also possible that residual confounding remains attributable to our inability to capture certain additional information about the transfer-in patients that may explain their better than expected outcomes.
We observed a mortality concentrating effect at our center, where transfer-in patients accounted for an absolute 1% increase and a relative 8.5% increase in our overall mortality. Although we observed no risk-adjusted impact on mortality, there is likely limited power to detect the true differences, if present. Public reporting of healthcare quality data has become a common policy strategy to improve transparency, accountability, and quality. The National Quality Forum recently endorsed the inclusion of mortality among the other 17 National Quality Forum-endorsed voluntary consensus standards. The Center for Medicare and Medicaid Services (CMS) is also considering the inclusion of stroke mortality measures for public reporting purposes as well as value-based purchasing. Inclusion of a mortality measure has raised many questions, most important of which is the role of risk adjustment to account for baseline differences in severity. If our findings are generalizable, then comprehensive stroke care centers may be expected to admit more patients who are severely disabled in transfer versus those that present directly to the front door. If risk-adjusted mortality measures do not account for stroke severity, then these hospitals may be unfairly classified as having greater than expected mortality. This could create perverse incentives for comprehensive stroke centers to discourage transfer of the sickest patients most in need of their services.
Our study has limitations. The data collection method in this study is based on site-level retrospective chart review by a trained data abstractor and therefore depends on the accuracy and reliability of chart documentation and the quality of abstraction. In addition, although we do have comfort measures only status captured in the GWTG database, do not resuscitate orders or other limitations on life-sustaining treatments are not captured. Therefore, we could not explore the role of a prior do not resuscitate order, or the application of a do not resuscitate order, on the likelihood of mortality. This experience is based on a single center with a larger referral area and a well-developed telestroke network, and so the results may not be generalizable to other advanced stroke centers/comprehensive stroke centers. Larger multicenter studies should be performed to verify our results. Residual measured and unmeasured confounding may Demographics, clinical characteristics, in-hospital complications, and outcomes among patients with acute ischemic stroke receiving intravenous tissue plasminogen activator (IV tPA) presenting front door versus transfersin during the 8-year period from 2005 to 2012 are presented in the table. CAD indicates coronary artery disease; IA therapy, intra-arterial therapy; IQR, interquartile range; IRF, inpatient rehabilitation facility; MGH, Massachusetts General Hospital; MI, myocardial infarction; NIHSS, National Institutes of Health Stroke Scale; SNF, skilled nursing facility; and UTI, urinary tract infection. by guest on September 8, 2017 http://stroke.ahajournals.org/ Downloaded from have influenced the findings, especially as it relates to stroke subtype and initial stroke severity.
Transfers of care to our stroke center were common, and these patients were more disabled on arrival. Yet, transfer-in patients had similar in-hospital mortality and increased frequency of discharge to rehabilitation facilities. These outcomes support the concept of regionalized stroke care and concentrating patients with severe strokes at more advanced centers.
